Report cover image

RT-PCR Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Reagents & Consumables, Instruments, and Software & Services), Application (Research Application, Clinical Applic

Publisher The Insight Partners
Published Jan 13, 2026
Length 274 Pages
SKU # TIP20855162

Description

According to our new research study on “RT-PCR Market Forecast to 2031 –Global Analysis – by Product, Application, and End User,” the market is anticipated to grow from US$2.71 billion in 2024 to US$4.47 billion by 2031; the market is expected to register a CAGR of 7.5% from 2025 to 2031. The RT-PCR Market growth is attributed to the demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in RT-PCR technology and automation.

Reverse Transcription Polymerase Chain Reaction (RT-PCR) is a laboratory technique used to detect and measure RNA by converting it into complementary DNA (cDNA) through reverse transcription, followed by amplification using PCR. It is widely used for viral detection, gene expression analysis, and molecular diagnostics because of its high sensitivity and specificity. RT-PCR played a critical role during the COVID-19 pandemic for identifying SARS-CoV-2 infections. The technique enables early disease detection, monitoring of viral load, and research into genetic activity, making it an essential tool in clinical diagnostics, biomedical research, and public health surveillance worldwide.

The geographical scope of the RT-PCR market report includes the assessment of the market performance in North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa. The North America RT-PCR market is propelled by the ongoing demand for rapid and accurate diagnostic testing, especially highlighted by recent infectious disease outbreaks. In the US, the CDC reported over 120 million COVID-19 cases by 2022, emphasizing the crucial role of RT-PCR testing in managing the pandemic. According to the CDC and FDA reports, the prevalence of COVID-19 continued to influence testing strategies in 2023 and 2024, with estimates indicating that millions of tests were conducted monthly to monitor and control the virus's spread. Additionally, the increasing incidence of other infectious diseases, such as influenza and respiratory syncytial virus (RSV), has further boosted testing demand.

The RT-PCR market outlook indicates that Asia Pacific is expected to register the fastest growth in the coming years, supported by increasing incidence of infectious diseases and advancements in diagnostic technologies. According to the World Health Organization (WHO), the region reported nearly 700 million cases of infectious diseases in 2022, with projections indicating continued upward trends due to urbanization and population density, especially in countries such as India and China. In India, the Ministry of Health and Family Welfare reported over 200,000 new COVID-19 cases in early 2023, underlining the ongoing demand for effective diagnostic solutions. By 2024, the requirement for RT-PCR testing is expected to persist, particularly as respiratory infections continue to pose significant health challenges.

Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine to Provide Market Opportunities in Future

According to the World Health Organization (WHO), global cancer incidence reached 20 million new cases in 2022, rising to 20.3 million in 2023 and 20.5 million in 2024, with RT-PCR enabling oncogene profiling in 60% of cases for targeted therapies. In the US, the National Cancer Institute (NCI) reported 1.9 million new cases in 2022, increasing to 2.0 million in 2023 and 2.041 million in 2024, where RT-PCR validated biomarkers in 70% of precision trials. In Europe, the European Cancer Information System (ECIS) estimated 2.74 million new cases in the EU-27 in 2022, rising to 2.78 million in 2023 and 2.82 million in 2024, with RT-PCR facilitating gene fusion testing in 50% of lung cancer diagnoses.

Recent product developments include the FDA’s approval of Guardant Health’s Guardant Reveal, an RT-PCR-based liquid biopsy for detecting colorectal cancer recurrence, in August 2024, following the company’s oncology panel expansion in 2023. Additionally, the European Medicines Agency (EMA) authorized Roche’s FoundationOne CDx in 2023 for RT-PCR-based gene fusion testing. Other instances encompass the NIH's 2024 allocation of US$200 million for precision oncology, where RT-PCR validated biomarkers in 500 studies in 2023, improving targeted therapy accuracy by 25%. These innovations present opportunities for RT-PCR in companion diagnostics, advancing tailored cancer care.

World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the RT-PCR Market report.

Reasons to Buy

Saves and reduces time required for identifying the market growth, size, leading players, and segments in the global RT-PCR market.
Highlights key business priorities to assist companies in realigning their business strategies
Emphasizes key findings and recommendations that uncover emerging industry trends in the global RT-PCR market, enabling stakeholders across the value chain to craft effective long-term strategies
Develop/modify business expansion plans by analyzing substantial growth prospects in mature and emerging markets
Scrutinizes in-depth global RT-PCR market trends, along with factors driving the market, as well as those hindering it
Enhances the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Table of Contents

274 Pages
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. RT-PCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. RT-PCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Surging Global Infectious Disease Outbreaks Necessitating Rapid Diagnostic Capabilities
5.1.2 Escalating Cancer Incidence Driving Oncogene Detection and Personalized Diagnostics
5.1.3 Advancing Genetic Testing for Precision Medicine and Hereditary Disorders
5.2 Market Restraints
5.2.1 High Costs and Limited Accessibility of RT-PCR Testing Kits
5.2.2 Supply Chain Disruptions and Shortage of Reagents and Consumables
5.2.3 Regulatory Challenges and Lengthy Approval Processes
5.3 Market Opportunities
5.3.1 Expansion in Point-of-Care RT-PCR for Rapid Infectious Disease Response
5.3.2 Integration of RT-PCR in Oncology for Biomarker-Driven Personalized Medicine
5.3.3 Advancements in RT-PCR for Genetic Screening and Precision Health
5.4 Future Trends
5.4.1 Increasing Adoption of Multiplex RT-PCR Assays
5.4.2 Integration of Point-of-Care and Portable RT-PCR Devices
5.4.3 Advances in Automated and High-Throughput RT-PCR Technologies
5.5 Impact Analysis:
6. RT-PCR Market - Global Market Analysis
6.1 RT-PCR Market Revenue (US$ Mn), 2021 – 2031
7. Global RT-PCR Market – Revenue and Forecast to 2031 – by Product
7.1 Overview
7.2 RT-PCR Market Revenue Share, by Product, 2021 & 2031(%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8. Global RT-PCR Market – Revenue and Forecast to 2031 – by Application
8.1 Overview
8.2 RT-PCR Market Revenue Share, by Application, 2021 & 2031(%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
8.4.2.1 RT-PCR Market, by Clinical Application, 2021–2031 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9. Global RT-PCR Market – Revenue and Forecast to 2031 – by End-User
9.1 Overview
9.2 RT-PCR Market Revenue Share, by End-User, 2021 & 2031(%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)
10. RT-PCR Market - Geographical Analysis
10.1 North America RT-PCR Market, Revenue and Forecast To 2031
10.1.1 Overview
10.1.2 North America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.3 North America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.4 North America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.4.1 North America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5 North America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.1 North America RT-PCR Market, by Country
10.1.5.2 US
10.1.5.2.1 US RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.2.2 US: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.2.3 US: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.2.4.1 US: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.2.5 US: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Canada RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.3.2 Canada: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.3.3 Canada: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.3.4.1 Canada: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.3.5 Canada: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Mexico RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.4.2 Mexico: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.1.5.4.3 Mexico: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.1.5.4.3.1 Mexico: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.4.4 Mexico: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2 Europe RT-PCR Market, Revenue and Forecast to 2031
10.2.1 Overview
10.2.2 Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.3 Europe: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.4 Europe: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.4.1 Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5 Europe: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.1 Europe RT-PCR Market, by Country
10.2.5.2 UK
10.2.5.2.1 UK RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.2.2 UK: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.2.3 UK: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.2.3.1 UK: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.2.4 UK: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.3 Germany
10.2.5.3.1 Germany RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.3.2 Germany: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.3.3 Germany: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.3.3.1 Germany: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.4 Germany: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.4 France
10.2.5.4.1 France RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.4.2 France: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.4.3 France: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.4.3.1 France: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.4.4 France: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.5 Italy
10.2.5.5.1 Italy RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.5.2 Italy: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.5.3 Italy: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.5.3.1 Italy: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.5.4 Italy: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.6 Spain
10.2.5.6.1 Spain RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.6.2 Spain: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.6.3 Spain: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.6.3.1 Spain: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.5 Spain: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.2.5.7 Rest of Europe
10.2.5.7.1 Rest of Europe RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.7.2 Rest of Europe: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.2.5.7.3 Rest of Europe: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.2.5.7.3.1 Rest of Europe: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.7.4 Rest of Europe: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3 Asia Pacific RT-PCR Market, Revenue and Forecast to 2031
10.3.1 Overview
10.3.2 Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.3 Asia Pacific: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.4 Asia Pacific: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.4.1 Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5 Asia Pacific: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.1 Asia Pacific RT-PCR Market, by Country
10.3.5.2 China
10.3.5.2.1 China RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 China: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.2.3 China: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.2.3.1 China: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 China: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.3 Japan
10.3.5.3.1 Japan RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 Japan: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.3.3 Japan: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.3.3.1 Japan: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.4 Japan: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.4 India
10.3.5.4.1 India RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 India: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.4.3 India: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.4.3.1 India: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 India: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.5 Australia
10.3.5.5.1 Australia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Australia: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.5.3 Australia: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.5.3.1 Australia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Australia: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.6 South Korea
10.3.5.6.1 South Korea RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.6.2 South Korea: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.6.3 South Korea: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.6.3.1 South Korea: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.6.4 South Korea: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.7 Rest of Asia Pacific
10.3.5.7.1 Rest of Asia Pacific RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.7.2 Rest of Asia Pacific: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.7.3 Rest of Asia Pacific: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.7.3.1 Rest of Asia Pacific: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.7.4 Rest of Asia Pacific: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.4 Middle East & Africa RT-PCR Market, Revenue and Forecast to 2031
10.4.1 Overview
10.4.2 Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.4.3 Middle East & Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.4.4 Middle East & Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.4.4.1 Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.4.5 Middle East & Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.1 Middle East & Africa RT-PCR Market, by Country
10.3.5.2 Saudi Arabia
10.3.5.2.1 Saudi Arabia RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 Saudi Arabia: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.2.3 Saudi Arabia: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.2.3.1 Saudi Arabia: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 Saudi Arabia: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.3 UAE
10.3.5.3.1 UAE RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 UAE: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.3.3 UAE: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.3.3.1 UAE: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.5 UAE: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.4 South Africa
10.3.5.4.1 South Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 South Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.4.3 South Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.4.3.1 South Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 South Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.3.5.5 Rest of Middle East & Africa
10.3.5.5.1 Rest of Middle East & Africa RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Rest of Middle East & Africa: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.3.5.5.3 Rest of Middle East & Africa: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.3.5.5.3.1 Rest of Middle East & Africa: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Rest of Middle East & Africa: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5 South & Central America RT-PCR Market, Revenue and Forecast to 2031
10.5.1 Overview
10.5.2 South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.3 South & Central America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.4 South & Central America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.4.1 South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5 South & Central America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.1 South & Central America RT-PCR Market, by Country
10.5.5.2 Brazil
10.5.5.2.1 Brazil RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.2.2 Brazil: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.2.3 Brazil: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.2.3.1 Brazil: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.2.4 Brazil: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.3 Argentina
10.5.5.3.1 Argentina RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.3.2 Argentina: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.3.3 Argentina: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.3.3.1 Argentina: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.3.4 Argentina: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
10.5.5.4 Rest of South & Central America
10.5.5.4.1 Rest of South & Central America RT-PCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.4.2 Rest of South & Central America: RT-PCR Market, by Product, 2021–2031 (US$ Million)
10.5.5.4.3 Rest of South & Central America: RT-PCR Market, by Application, 2021–2031 (US$ Million)
10.5.5.4.3.1 Rest of South & Central America: RT-PCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.4.4 Rest of South & Central America: RT-PCR Market, by End-User, 2021–2031 (US$ Million)
11. RT-PCR Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in RT-PCR Market
11.3 Organic Growth Strategies
11.3.1 Overview
11.4 Inorganic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Thermo Fisher Scientific Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Takara Bio Inc
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Qiagen NV
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Hologic Inc
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 bioMerieux SALtd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 F. Hoffmann-La Roche Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Bio-Rad Laboratories Inc
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Agilent Technologies Inc
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Promega CorpPvt Ltd
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 SWOT Analysis
12.10.5 Key Developments
13. Appendix
13.1 About Us
13.2 Glossary of Terms
Table 1. RT-PCR Market Segmentation
Table 2. RT-PCR Market, by Clinical Application – Revenue and Forecast to 2031 (US$ Million)
Table 3. North America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 4. North America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 5. North America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 6. North America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 7. US RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 8. US RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 9. US RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 10. US RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 11. Canada RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 12. Canada RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 13. Canada RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 14. Canada RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 15. Mexico RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 16. Mexico RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 17. Mexico RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 18. Mexico RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 19. Europe RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 20. Europe RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 21. Europe RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 22. Europe RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 23. UK RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 24. UK RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 25. UK RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 26. UK RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 27. Germany RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 28. Germany RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 29. Germany RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 30. Germany RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 31. France RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 32. France RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 33. France RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 34. France RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 35. Italy RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 36. Italy RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 37. Italy RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 38. Italy RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 39. Spain RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 40. Spain RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 41. Spain RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 42. Spain RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 43. Rest of Europe RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 44. Rest of Europe RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 45. Rest of Europe RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 46. Rest of Europe RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 47. Asia Pacific RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 48. Asia Pacific RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 49. Asia Pacific RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 50. Asia Pacific RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 51. China RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 52. China RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 53. China RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 54. China RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 55. Japan RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 56. Japan RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 57. Japan RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 58. Japan RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 59. India RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 60. India RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 61. India RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 62. India RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 63. Australia RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 64. Australia RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 65. Australia RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 66. Australia RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 67. South Korea RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 68. South Korea RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 69. South Korea RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 70. South Korea RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 71. Rest of Asia Pacific RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 72. Rest of Asia Pacific RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 73. Rest of Asia Pacific RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 74. Rest of Asia Pacific RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 75. Middle East & Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 76. Middle East & Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 77. Middle East & Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 78. Middle East & Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 79. Saudi Arabia RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 80. Saudi Arabia RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 81. Saudi Arabia RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 82. Saudi Arabia RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 83. UAE RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 84. UAE RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 85. UAE RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 86. UAE RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 87. South Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 88. South Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 89. South Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 90. South Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 91. Rest of Middle East & Africa RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 92. Rest of Middle East & Africa RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 93. Rest of Middle East & Africa RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 94. Rest of Middle East & Africa RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 95. South & Central America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 96. South & Central America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 97. South & Central America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 98. South & Central America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 99. Brazil RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 91. Brazil RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 92. Brazil RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 93. Brazil RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 94. Argentina RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 95. Argentina RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 96. Argentina RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 97. Argentina RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 98. Rest of South & Central America RT-PCR Market, by Product – Revenue and Forecast to 2031 (US$ Million)
Table 99. Rest of South & Central America RT-PCR Market, by Application – Revenue and Forecast to 2031 (US$ Million)
Table 100. Rest of South & Central America RT-PCR Market, for Clinical Application by Application – Revenue and Forecast to 2031 (US$ Million)
Table 101. Rest of South & Central America RT-PCR Market, by End-User – Revenue and Forecast to 2031 (US$ Million)
Table 102. Recent Organic Growth Strategies in RT-PCR Market
Table 103. Recent Inorganic Growth Strategies in the RT-PCR Market
Table 104. Glossary of Terms, RT-PCR Market
Figure 1. RT-PCR Market Segmentation, By Geography
Figure 2. Global - PEST Analysis
Figure 3. RT-PCR Market - Key Industry Dynamics
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. RT-PCR Market Revenue (US$ Mn), 2021 – 2031
Figure 6. RT-PCR Market Revenue, Geography (US$ Mn), 2021 – 2031
Figure 7. Quantitative PCR: RT-PCR Market – Revenue and Forecast to 2031 (US$ Million)

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us